Gene · 926
Papers3,225
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,225
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Combining cell-free RNA with cell-free DNA in liquid biopsy for hematologic and solid tumors. | Heliyon | 2023 | 37251903 | PubTator, text mining | PubMed |
| Significance of Immunogenic Cell Death-Related Prognostic Gene Signature in Cervical Cancer Prognosis and Anti-Tumor Immunity. | J Inflamm Res | 2023 | 37250106 | PubTator, text mining | PubMed |
| BASP1 expression is associated with poor prognosis and is correlated with immune infiltration in gastric cancer. | FEBS Open Bio | 2023 | 37243901 | PubTator, text mining | PubMed |
| IL5RA as an immunogenic cell death-related predictor in progression and therapeutic response of multiple myeloma. | Sci Rep | 2023 | 37236993 | PubTator, text mining | PubMed |
| Down-regulation of S1PR2 is correlated with poor prognosis and immune infiltrates in cervical squamous cell carcinoma and endocervical adenocarcinoma. | Int J Immunopathol Pharmacol | 2023 | 37232164 | PubTator, text mining | PubMed |
| Identification of cervical cancer stem cells using single-cell transcriptomes of normal cervix, cervical premalignant lesions, and cervical cancer. | EBioMedicine | 2023 | 37224771 | PubTator, text mining | PubMed |
| RNA demethylase ALKBH5 suppresses tumorigenesis via inhibiting proliferation and invasion and promoting CD8+ T cell infiltration in colorectal cancer. | Transl Oncol | 2023 | 37224767 | PubTator, text mining | PubMed |
| Immunogenomic Landscape of Neuroendocrine Prostate Cancer. | Clin Cancer Res | 2023 | 37223924 | PubTator, text mining | PubMed |
| A novel immunogenic cell death-related subtype classification and risk signature for predicting prognosis and immunotherapy efficacy in gastric cancer. | Front Immunol | 2023 | 37215130 | PubTator, text mining | PubMed |
| LAPTM4B-YAP loop feedback amplification enhances the stemness of hepatocellular carcinoma. | iScience | 2023 | 37213231 | PubTator, text mining | PubMed |
| An integrated tumor, immune and microbiome atlas of colon cancer. | Nat Med | 2023 | 37202560 | PubTator, text mining | PubMed |
| Clonally expanded, thyrotoxic effector CD8+ T cells driven by IL-21 contribute to checkpoint inhibitor thyroiditis. | Sci Transl Med | 2023 | 37196065 | PubTator, text mining | PubMed |
| Non-Inflamed Tumor Microenvironment and Methylation/Downregulation of Antigen-Presenting Machineries in Cholangiocarcinoma. | Cancers (Basel) | 2023 | 37190307 | PubTator, text mining | PubMed |
| Generative pretraining from large-scale transcriptomes for single-cell deciphering. | iScience | 2023 | 37187700 | PubTator, text mining | PubMed |
| Manual cell selection in single cell transcriptomics using scSELpy supports the analysis of immune cell subsets. | Front Immunol | 2023 | 37180117 | PubTator, text mining | PubMed |
| Immune landscape of breast tumors with low and intermediate estrogen receptor expression. | NPJ Breast Cancer | 2023 | 37179445 | PubTator, text mining | PubMed |
| ARPC5 isoforms and their regulation by calcium-calmodulin-N-WASP drive distinct Arp2/3-dependent actin remodeling events in CD4 T cells. | Elife | 2023 | 37162507 | PubTator, text mining | PubMed |
| Glioma immunotherapy enhancement and CD8-specific sialic acid cleavage by isocitrate dehydrogenase (IDH)-1. | Oncogene | 2023 | 37161052 | PubTator, text mining | PubMed |
| RGN as a prognostic biomarker with immune infiltration and ceRNA in lung squamous cell carcinoma. | Sci Rep | 2023 | 37161020 | PubTator, text mining | PubMed |
| The single-cell transcriptional landscape of innate and adaptive lymphocytes in pediatric-onset colitis. | Cell Rep Med | 2023 | 37160121 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/926/papers?page=20